Advertisement
Screener

Kiniksa Pharmaceuticals International, plc (KNSA) Increase (Decrease) in Other Noncurrent Assets

2.8 / 5 stars · 68/120 Roast Me

Kiniksa Pharmaceuticals International, plc Increase (Decrease) in Other Noncurrent Assets

Kiniksa Pharmaceuticals International, plc (KNSA) reported Increase (Decrease) in Other Noncurrent Assets of -$125.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-04-28

  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$125.00K.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $3.04M, a 20.52% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $143.00K, a 1330.00% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $70.00K, a 98.18% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for fiscal 2025 was $1.21M, a 87.57% decline from fiscal 2024.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for fiscal 2024 was $9.73M.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for fiscal 2023 was -$4.58M.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in other noncurrent assets for fiscal 2022 was -$2.65M, a 180.82% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Noncurrent Assets 3 monthIncrease (Decrease) in Other Noncurrent Assets 6 monthIncrease (Decrease) in Other Noncurrent Assets 9 monthIncrease (Decrease) in Other Noncurrent Assets 12 month
2026-03-31-$125.00K
10-Q · filed 2026-04-28
$2.92M
derived: sum of 2 quarters · filed 2026-04-28
$3.06M
derived: sum of 3 quarters · filed 2026-04-28
$3.13M
derived: sum of 4 quarters · filed 2026-04-28
2025-12-31$3.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$3.19M
derived: sum of 2 quarters · filed 2026-02-24
$3.25M
derived: sum of 3 quarters · filed 2026-02-24
$1.21M
10-K · filed 2026-02-24
2025-09-30$143.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$213.00K
derived: sum of 2 quarters · filed 2025-10-28
-$1.83M
10-Q · filed 2025-10-28
$692.00K
derived: sum of 4 quarters · filed 2026-04-28
2025-06-30$70.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
-$1.98M
10-Q · filed 2025-07-29
$549.00K
derived: sum of 3 quarters · filed 2026-04-28
$559.00K
derived: sum of 4 quarters · filed 2026-04-28
2025-03-31-$2.04M
10-Q · filed 2026-04-28
$479.00K
derived: sum of 2 quarters · filed 2026-04-28
$489.00K
derived: sum of 3 quarters · filed 2026-04-28
$4.33M
derived: sum of 4 quarters · filed 2026-04-28
2024-12-31$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$2.53M
derived: sum of 2 quarters · filed 2026-02-24
$6.37M
derived: sum of 3 quarters · filed 2026-02-24
$9.73M
10-K · filed 2026-02-24
2024-09-30$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$3.85M
derived: sum of 2 quarters · filed 2025-10-28
$7.21M
10-Q · filed 2025-10-28
$5.80M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$3.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
$7.20M
10-Q · filed 2025-07-29
$5.79M
derived: sum of 3 quarters · filed 2026-02-24
$5.79M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$3.36M
10-Q · filed 2025-04-29
$1.96M
derived: sum of 2 quarters · filed 2026-02-24
$1.96M
derived: sum of 3 quarters · filed 2026-02-24
$2.05M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.41M
derived: sum of 2 quarters · filed 2026-02-24
-$1.32M
derived: sum of 3 quarters · filed 2026-02-24
-$4.58M
10-K · filed 2026-02-24
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$90.00K
derived: sum of 2 quarters · filed 2024-10-29
-$3.18M
10-Q · filed 2024-10-29
-$2.91M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$90.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25
-$3.18M
10-Q · filed 2024-07-25
-$2.91M
derived: sum of 3 quarters · filed 2025-02-25
-$2.91M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$3.27M
10-Q · filed 2024-04-25
-$3.00M
derived: sum of 2 quarters · filed 2025-02-25
-$3.00M
derived: sum of 3 quarters · filed 2025-02-25
-$3.17M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$265.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$264.00K
derived: sum of 2 quarters · filed 2025-02-25
$101.00K
derived: sum of 3 quarters · filed 2025-02-25
-$2.65M
10-K · filed 2025-02-25
2022-09-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$164.00K
derived: sum of 2 quarters · filed 2023-11-02
-$2.92M
10-Q · filed 2023-11-02
-$694.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$163.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$2.92M
10-Q · filed 2023-08-01
-$693.00K
derived: sum of 3 quarters · filed 2024-02-28
$87.00K
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$2.75M
10-Q · filed 2023-05-04
-$530.00K
derived: sum of 2 quarters · filed 2024-02-28
$250.00K
derived: sum of 3 quarters · filed 2024-02-28
$298.00K
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$2.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$3.00M
derived: sum of 2 quarters · filed 2024-02-28
$3.05M
derived: sum of 3 quarters · filed 2024-02-28
$3.28M
10-K · filed 2024-02-28
2021-09-30$780.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$828.00K
derived: sum of 2 quarters · filed 2022-11-03
$1.06M
10-Q · filed 2022-11-03
2021-06-30$48.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$279.00K
10-Q · filed 2022-08-04
2021-03-31$231.00K
10-Q · filed 2022-05-05
2020-12-31$5.59M
10-K · filed 2023-03-02